Entrada Therapeutics
TRDA
TRDA
106 hedge funds and large institutions have $210M invested in Entrada Therapeutics in 2025 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 45 increasing their positions, 23 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
106
Holders Change
-5
Holders Change %
-4.5%
% of All Funds
1.42%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
21
Increased
45
Reduced
23
Closed
26
Calls
$144K
Puts
–
Net Calls
+$144K
Net Calls Change
+$41K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
PFBT
126
Parkside Financial Bank & Trust
Saint Louis,
Missouri
| – | -$362 | -40 | Closed |
|
|
FFO
127
Fortitude Family Office
Scottsdale,
Arizona
| – | -$334 | -37 | Closed |
|
|
CCM
128
Coldstream Capital Management
Bellevue,
Washington
| – | -$298 | -33 | Closed |
|
|
CMBA
129
C.M. Bidwell & Associates
Honolulu,
Hawaii
| – | -$262 | -29 | Closed |
|
|
RIL
130
Rothschild Investment LLC
Chicago,
Illinois
| – | -$181 | -20 | Closed |
|
131
Amundi
Paris,
France
| – | -$96 | -12 | Closed |
|
|
SS
132
SBI Securities
Tokyo,
Japan
| – | -$9 | -1 | Closed |
|